[go: up one dir, main page]

DE69830114D1 - Analgetische Zusammensetzung welche Moxonidine und ein Opioid-Analgetika enthält - Google Patents

Analgetische Zusammensetzung welche Moxonidine und ein Opioid-Analgetika enthält

Info

Publication number
DE69830114D1
DE69830114D1 DE69830114T DE69830114T DE69830114D1 DE 69830114 D1 DE69830114 D1 DE 69830114D1 DE 69830114 T DE69830114 T DE 69830114T DE 69830114 T DE69830114 T DE 69830114T DE 69830114 D1 DE69830114 D1 DE 69830114D1
Authority
DE
Germany
Prior art keywords
analgesic
opioid
composition containing
moxonidine
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69830114T
Other languages
English (en)
Inventor
Carolyn A Fairbanks
George L Wilcox
Laura S Stone
Kelley F Kitto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Solvay Pharmaceuticals GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals GmbH filed Critical Solvay Pharmaceuticals GmbH
Application granted granted Critical
Publication of DE69830114D1 publication Critical patent/DE69830114D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69830114T 1997-09-16 1998-09-14 Analgetische Zusammensetzung welche Moxonidine und ein Opioid-Analgetika enthält Expired - Lifetime DE69830114D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5895497P 1997-09-16 1997-09-16

Publications (1)

Publication Number Publication Date
DE69830114D1 true DE69830114D1 (de) 2005-06-16

Family

ID=22019930

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69830114T Expired - Lifetime DE69830114D1 (de) 1997-09-16 1998-09-14 Analgetische Zusammensetzung welche Moxonidine und ein Opioid-Analgetika enthält

Country Status (4)

Country Link
US (1) US6204271B1 (de)
EP (1) EP0906757B1 (de)
AT (1) ATE295171T1 (de)
DE (1) DE69830114D1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2543385A1 (de) * 2002-01-21 2013-01-09 NRL Pharma, Inc. Neuartige Analgetika
WO2004000312A2 (de) * 2002-06-19 2003-12-31 Solvay Pharmaceuticals Gmbh Arzneimittel zur behandlung von eine inhibition oder aktivitätsverminderung von ph-wert-regulierenden bikarbonat-transporter-proteinen erfordernden erkrangungen
WO2004058286A1 (en) * 2002-12-18 2004-07-15 Algorx Pharmaceuticals, Inc. Administration of capsaicinoids
US20040186182A1 (en) * 2002-12-18 2004-09-23 Algorx Administration of capsaicinoids
US20050085652A1 (en) * 2003-04-08 2005-04-21 Algorx Pharmaceuticals, Inc. Preparation and purification of synthetic capsaicin
US20060148903A1 (en) * 2004-11-24 2006-07-06 Algorx Pharmaceuticals, Inc. Capsaicinoid gel formulation and uses thereof
US20110269759A1 (en) * 2009-10-30 2011-11-03 Coats Steven J Pyrimidine compounds as delta opioid receptor modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU166378B (de) * 1972-12-19 1975-03-28
US5840731A (en) * 1995-08-02 1998-11-24 Virginia Commonwealth University Pain-alleviating drug composition and method for alleviating pain

Also Published As

Publication number Publication date
US6204271B1 (en) 2001-03-20
ATE295171T1 (de) 2005-05-15
EP0906757A2 (de) 1999-04-07
EP0906757B1 (de) 2005-05-11
EP0906757A3 (de) 2001-05-16

Similar Documents

Publication Publication Date Title
DE69536035D1 (de) Schmelzextrudierte oral verabreichbare Opioidformulierungen
DE69822168D1 (de) Dentale anästhesie- und verabreichungsinjektionseinheit
NZ503233A (en) Synergistic analgesic combination of opioid analgesic and COX-2 inhibitor
HUP0002645A3 (en) Phospholipid containing pharmaceutical composition for treating sleep apnea and apparatus for enabling the administration thereof
ATE210983T1 (de) Stabilisiertes kombinationsarzneimittel enthaltend naloxone und ein opiatanalgetikum
FI954228A0 (fi) Infuusiolaite hoitoaineen jaksottaista tai jatkuvaa antamista varten
NZ336865A (en) Use of a therapeutic agent containing a neurotrophic factor for treatment of diabetes and hyperlipemia
EP0761173A3 (de) Nadel zum Verabreichen therapeutischer Lösungen in den Subarachnoidalraum
ATE283695T1 (de) Verwendungen und zusammenstellungen von nitratestern als sedativa
DE69531098D1 (de) Piperidine und pyrrolidine
ES2099344T3 (es) Preparado de combinacion a base de flupirtina y morfina para el tratamiento de dolores y para evitar la adiccion a morfina.
EE04493B1 (et) Tsüklopenteeni derivaadid, neid sisaldav farmatseutiline kompositsioon ning ühendite kasutamine ravimina inimestel esinevate motiliini retseptoriga seotud häirete raviks
GB2305606B (en) Drug delivery composition for the nasal administration of ICAM-1
ITMI930582A0 (it) Composizione farmeceutiche ad attivita' analgesica
EP0683668A4 (de) Präparate und verfahren für eine transdermale arzneistoffverabreichung.
ATE295171T1 (de) Analgetische zusammensetzung welche moxonidine und ein opioid-analgetika enthält
ITMI931325A0 (it) Composizione farmaceutica ad attivita' analgesica
FR2735132B1 (fr) Medicament polypeptidique modifie, composition et dispositif d'administration par electrotransport le contenant
FI964619A7 (fi) Epilepsialääkkeiden iholle annostelu
EE03205B1 (et) Ropivakaiini kasutamine valuvaigistina kasutatava ravimpreparaadi valmistamiseks
DK408188A (da) Injicerbart middel til kontrolleret frigivelse af opioid-analgetika
BR9801839A (pt) Medicamento analgésico e aplicação de (+) -0-demetiltramadol.
SE9803623D0 (sv) New therapeutic application
FI930097A7 (fi) Annostusmuoto lääkeaineen antamiseksi vuorokausiterapian toteuttamista varten
IT1288708B1 (it) Composizione farmaceutica comprendente trometamina per il trattamento per via topica dell'acne vulgaris.

Legal Events

Date Code Title Description
8332 No legal effect for de